Tom Boyles to Mycobacterium tuberculosis
This is a "connection" page, showing publications Tom Boyles has written about Mycobacterium tuberculosis.
Connection Strength
2,146
-
Xpert Ultra's place in the diagnosis of tuberculous meningitis. Lancet Infect Dis. 2018 03; 18(3):248-249.
Score: 0,459
-
Why do clinical trials of Xpert® MTB/RIF fail to show an effect on patient relevant outcomes? Int J Tuberc Lung Dis. 2017 03 01; 21(3):249-250.
Score: 0,428
-
False-positive Xpert(®) MTB/RIF assays and previous treatment. Int J Tuberc Lung Dis. 2015 Apr; 19(4):495-6.
Score: 0,375
-
False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results. Int J Tuberc Lung Dis. 2014 Jul; 18(7):876-8.
Score: 0,356
-
The pros and cons of urinary lipoarabinomannan testing. AIDS. 2012 Nov 13; 26(17):2263-4; author reply 2264-5.
Score: 0,318
-
Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV. Int J Infect Dis. 2018 Oct; 75:67-73.
Score: 0,118
-
Appropriate use of the Xpert® MTB/RIF assay in suspected tuberculous meningitis. Int J Tuberc Lung Dis. 2015 Mar; 19(3):276-7.
Score: 0,093